• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合特征研究:对 CYP2A6 与抑制剂相互作用的影响。

Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors.

机构信息

Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.

出版信息

J Comput Chem. 2010 Jul 15;31(9):1822-31. doi: 10.1002/jcc.21455.

DOI:10.1002/jcc.21455
PMID:20336802
Abstract

A computational investigation has been carried out on CYP2A6 and its naphthalene inhibitors to explore the crucial molecular features contributing to binding specificity. The molecular bioactive orientations were obtained by docking (FlexX) these compounds into the active site of the enzyme. And the density functional theory method was further used to optimize the molecular structures with the subsequent analysis of molecular lipophilic potential (MLP) and molecular electrostatic potential (MEP). The minimal MLPs, minimal MEPs, and the band gap energies (the energy difference between the highest occupied molecular orbital and lowest unoccupied molecular orbital) showed high correlations with the inhibition activities (pIC(50)s), illustrating their significant roles in driving the inhibitor to adopt an appropriate bioactive conformation oriented in the active site of CYP2A6 enzyme. The differences in MLPs, MEPs, and the orbital energies have been identified as key features in determining the binding specificity of this series of compounds to CYP2A6 and the consequent inhibitory effects. In addition, the combinational use of the docking, MLP and MEP analysis is also demonstrated as a good attempt to gain an insight into the interaction between CYP2A6 and its inhibitors.

摘要

已经对 CYP2A6 及其萘抑制剂进行了计算研究,以探索有助于结合特异性的关键分子特征。通过将这些化合物对接(FlexX)到酶的活性部位,获得了分子生物活性取向。然后使用密度泛函理论方法进一步优化分子结构,并进行分子亲脂性势能(MLP)和分子静电势(MEP)分析。最小 MLP、最小 MEP 和能带隙能量(最高占据分子轨道和最低未占据分子轨道之间的能量差)与抑制活性(pIC(50))呈高度相关性,表明它们在驱动抑制剂采用适当的生物活性构象方面起着重要作用,该构象定向于 CYP2A6 酶的活性部位。MLP、MEP 和轨道能量的差异被确定为决定这一系列化合物与 CYP2A6 结合特异性和随之而来的抑制作用的关键特征。此外,对接、MLP 和 MEP 分析的组合使用也被证明是深入了解 CYP2A6 与其抑制剂之间相互作用的良好尝试。

相似文献

1
Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors.结合特征研究:对 CYP2A6 与抑制剂相互作用的影响。
J Comput Chem. 2010 Jul 15;31(9):1822-31. doi: 10.1002/jcc.21455.
2
Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.尼古丁代谢酶CYP2A6抑制剂的定量构效关系分析
J Med Chem. 2005 Jan 27;48(2):440-9. doi: 10.1021/jm049536b.
3
Identification of novel CYP2A6 inhibitors by virtual screening.通过虚拟筛选鉴定新型 CYP2A6 抑制剂。
Bioorg Med Chem. 2011 Dec 1;19(23):7186-93. doi: 10.1016/j.bmc.2011.09.054. Epub 2011 Oct 4.
4
Binding free energies for nicotine analogs inhibiting cytochrome P450 2A6 by a combined use of molecular dynamics simulations and QM/MM-PBSA calculations.通过结合分子动力学模拟和QM/MM-PBSA计算得出的尼古丁类似物抑制细胞色素P450 2A6的结合自由能。
Bioorg Med Chem. 2014 Apr 1;22(7):2149-56. doi: 10.1016/j.bmc.2014.02.037. Epub 2014 Mar 3.
5
Computational studies of novel chymase inhibitors against cardiovascular and allergic diseases: mechanism and inhibition.新型糜酶抑制剂治疗心血管和过敏疾病的计算研究:作用机制与抑制作用。
Chem Biol Drug Des. 2012 Dec;80(6):862-75. doi: 10.1111/cbdd.12006.
6
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approach.尼古丁代谢CYP2A6酶抑制剂的鉴定——一种计算机模拟方法。
Pharmacogenomics J. 2008 Oct;8(5):328-38. doi: 10.1038/sj.tpj.6500481. Epub 2007 Oct 9.
7
Conceptual DFT properties-based 3D QSAR: analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.基于概念性密度泛函理论性质的三维定量构效关系:尼古丁代谢酶CYP2A6抑制剂的分析
J Comput Chem. 2009 Sep;30(12):1749-57. doi: 10.1002/jcc.21177.
8
Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach.使用药效团集成/支持向量机(PhE/SVM)方法开发一种预测与人类细胞色素P450 2A6相互作用的新模型。
Pharm Res. 2009 Apr;26(4):987-1000. doi: 10.1007/s11095-008-9807-9. Epub 2008 Dec 23.
9
Study of inhibition of CYP2A6 by some drugs derived from quinoline.
J Pharm Pharmacol. 2003 Dec;55(12):1667-72. doi: 10.1211/0022357022278.
10
5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6.作为细胞色素P-450 2A6选择性抑制剂的尼古丁的5-取代、6-取代和未取代的3-杂芳基吡啶类似物。
J Med Chem. 2005 Jan 13;48(1):224-39. doi: 10.1021/jm049696n.

引用本文的文献

1
Pretraining graph transformers with atom-in-a-molecule quantum properties for improved ADMET modeling.利用分子中原子量子性质预训练图变换器以改进ADMET建模。
J Cheminform. 2025 Feb 27;17(1):25. doi: 10.1186/s13321-025-00970-0.
2
Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery.用于中药作用机制研究以助力药物发现的系统药理学
Front Pharmacol. 2019 Jul 11;10:743. doi: 10.3389/fphar.2019.00743. eCollection 2019.
3
Cytochrome P450 3A Enzymes Are Key Contributors for Hepatic Metabolism of Bufotalin, a Natural Constitute in Chinese Medicine Chansu.
细胞色素P450 3A酶是中药蟾酥中天然成分蟾毒灵肝脏代谢的关键贡献者。
Front Pharmacol. 2019 Feb 4;10:52. doi: 10.3389/fphar.2019.00052. eCollection 2019.
4
Ensemble-based virtual screening: identification of a potential allosteric inhibitor of Bcr-Abl.基于集成的虚拟筛选:Bcr-Abl潜在变构抑制剂的鉴定
J Mol Model. 2017 Jul;23(7):218. doi: 10.1007/s00894-017-3384-y. Epub 2017 Jul 1.
5
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification.DFG-in 型 FMS 样酪氨酸激酶 3(FLT3)的同源建模及基于结构的虚拟筛选以鉴定抑制剂
Sci Rep. 2015 Jun 29;5:11702. doi: 10.1038/srep11702.
6
Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.通过三维定量构效关系药效团模型发现的肿瘤标志物AKR1B10抑制剂的新型化学支架。
Acta Pharmacol Sin. 2015 Aug;36(8):998-1012. doi: 10.1038/aps.2015.17. Epub 2015 Jun 8.
7
Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.基于药效团的虚拟筛选和密度泛函理论方法鉴定新型丁酰胆碱酯酶抑制剂。
Acta Pharmacol Sin. 2012 Jul;33(7):964-78. doi: 10.1038/aps.2012.21. Epub 2012 Jun 11.
8
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors.三维定量构效关系药效团模型的开发、评价及其在潜在人肾素抑制剂发现中的应用。
BMC Bioinformatics. 2011 Dec 14;12 Suppl 14(Suppl 14):S4. doi: 10.1186/1471-2105-12-S14-S4.